HB 1565-FN (2022): relative to the opioid abatement trust fund.
Cite this page
Granite Record indexes the General Court’s record; it is not that record. Where a citation allows only one source, cite the General Court — every page here links to what it is drawn from. The date below is the day the page was read.
- MLA
- “HB 1565-FN (2022): relative to the opioid abatement trust fund.” Granite Record, https://graniterecord.org/bill/2022/hb1565. Accessed 24 Oct. 2026.
- APA
- Granite Record. (n.d.). HB 1565-FN (2022): relative to the opioid abatement trust fund. Retrieved 24 Oct. 2026, from https://graniterecord.org/bill/2022/hb1565
- Chicago
- Granite Record. “HB 1565-FN (2022): relative to the opioid abatement trust fund.” Accessed 24 Oct. 2026. https://graniterecord.org/bill/2022/hb1565.
- BibTeX
@misc{bill-2022-hb1565, title = {HB 1565-FN (2022): relative to the opioid abatement trust fund.}, howpublished = {Granite Record}, url = {https://graniterecord.org/bill/2022/hb1565}, note = {Accessed 24 Oct. 2026} }
HB 1565-FN (2022)
relative to the opioid abatement trust fund.
- Status: Referred for interim study
- Term: 2021-2022
- House committee: Ways and Means
- Subject: Miscellaneous
The Story
It was introduced on January 5, 2022 and referred to the House Ways and Means committee. The committee held a public hearing on January 11, 2022. The committee held work sessions on January 26, 2022, February 2, 2022, February 10, 2022 and February 24, 2022. The committee met in executive session on March 9, 2022 to vote on its recommendation. The committee voted unanimously, 21–0, to recommend that the House study it after the session ends, and the report was placed on the consent calendar. The committee held a work session on March 14, 2022. On March 15, 2022 the House voted to study it after the session ends on a voice vote. The committee held a work session on September 20, 2022. The committee reported back on its interim study of the bill: “Not Recommended for Future Legislation”, by a vote of 16 to 0.
Sponsors
- Rep. Judy Aron (R - Sull 7) (prime sponsor)
- Rep. Skip Rollins (R - Sull 6)
- Rep. Walter Stapleton (R - Sull 5)
- Rep. Dennis Acton (R - Rock 10)
- Rep. Mark Pearson (R - Rock 34)
- Rep. Joseph Depalma IV (R - Graf 1)
- Rep. Linda Massimilla (D - Graf 1)
Hearings and Sessions
- January 11, 2022, 2:00 PM: public hearing, House Ways and Means, LOB 202-204
- January 26, 2022, 9:30 AM: full committee work session, House Ways and Means, LOB 202-204
- February 2, 2022, 9:00 AM: full committee work session, House Ways and Means, LOB 202-204
- February 10, 2022, 9:30 AM: full committee work session, House Ways and Means, LOB 202-204
- February 24, 2022, 9:30 AM: full committee work session, House Ways and Means, LOB 202-204
- March 9, 2022, 10:00 AM: executive session, House Ways and Means, LOB 202-204
- March 14, 2022, 10:00 AM: subcommittee work session, House Ways and Means, LOB 104
- September 20, 2022, 10:30 AM: full committee work session, House Ways and Means, LOB 202-204
Votes
- March 15, 2022, House: Refer for Interim Study — voice vote, passed
The Docket
- January 5, 2022: Introduced 01/05/2022 and referred to Ways and Means
- January 11, 2022: Public Hearing: 01/11/2022 02:00 pm LOB 202-204
- January 26, 2022: Full Committee Work Session: 01/26/2022 09:30 am LOB 202-204
- February 2, 2022: Full Committee Work Session: 02/02/2022 09:00 am LOB 202-204
- February 10, 2022: Full Committee Work Session: 02/10/2022 09:30 am LOB 202-204
- February 24, 2022: Full Committee Work Session: 02/24/2022 09:30 am LOB 202-204
- March 9, 2022: Executive Session: 03/09/2022 10:00 am LOB 202-204
- March 10, 2022: Committee Report: Refer for Interim Study (Vote 21-0; CC)
- March 14, 2022: Subcommittee Work Session: 03/14/2022 10:00 am LOB 104
- March 15, 2022: Refer for Interim Study: MA VV 03/15/2022
- September 20, 2022: Interim Study Full Committee Work Session: 09/20/2022 10:30 am LOB 202-204
- October 19, 2022: Interim Study Report: Not Recommended for Future Legislation (Vote 16-0)